Advertisement
The Essential Resource for the Medical Design Engineering Community
Subscribe to MDT Magazine All

Tiny Needles to Fight Cancer

August 31, 2010 8:33 pm | by Massachusetts Institute of Technology | News | Comments

Researchers inject quantum dots into the skin using plastic microneedles, potentially providing a way to diagnose and treat diseases.

<i>Tech across New England: </i>NanoViricides leads disarming of viral infections

August 31, 2010 8:33 pm | by Mass High Tech: The Journal of New England Technology | News | Comments

Mass High Tech looked at startups poised to lead the economic recovery because of their technology, management team or growth potential. NanoViricides has developed a novel nanoviricide class of drug candidates designed to specifically attack life-threatening viral infections and dismantle them.

<i>Tech across New England: </i>Bar Harbor BioTechnology uses genetic tools for disease research

August 31, 2010 8:32 pm | by Mass High Tech: The Journal of New England Technology | News | Comments

Mass High Tech looked at startups poised to lead the economic recovery because of their technology, management team or growth potential. Bar Harbor BioTechnology manufactures tests that allow genetic researchers to measure and compare gene expression levels across time and populations.

TOPICS:
Advertisement

HCP, Sunrise reach $50M deal to end 27 contracts

August 31, 2010 2:45 pm | by The Associated Press | News | Comments

HCP Inc. on Tuesday said it reached a $50 million deal to terminate the contracts on 27 of its senior housing communities managed by Sunrise Senior Living Inc.HCP said it will enter into new arrangements for the 27 communities that will reflect improved operating margins. The changes will take...

Drug trial results refine treatment during angioplasty operations

August 31, 2010 2:36 pm | by EurekAlert | News | Comments

(McMaster University) A landmark international study, coordinated by McMaster University, has found that lower doses of a blood thinner called unfractionated heparin (UFH) during angioplasty did not reduce bleeding or vascular complications compared to standard dose UFH in patients...

TOPICS:

Success stops drug trial

August 31, 2010 2:36 pm | by EurekAlert | News | Comments

(McMaster University) The data monitoring committee of the AVERROES study, seeing overwhelming evidence of the success of apixaban in the prevention of stroke in patients with atrial fibrillation who are unsuitable for the conventional treatment of warfarin, has recommended early...

TOPICS:

Health advice from pharmacists saves hundreds of millions of euros

August 31, 2010 2:36 pm | by EurekAlert | News | Comments

(International Pharmaceutical Federation (FIP)) Hundreds of millions of euros are being saved each year for national health care systems by patients consulting community pharmacists rather than going straight to their doctors, says a survey to be presented at the annual conference...

TOPICS:

Masdar PV provides modules for BIPV (Building-integrated photovoltaics) façade

August 31, 2010 2:36 pm | by I-Micronews | News | Comments

Gehrlicher and Masdar PV have launched a pilot project for a PV façade installation Masdar PV, a manufacturer of extra-large thin-film PV modules, has now supplied PV modules for installation on a building façade for the first time.

Advertisement

Over EUR 300 million of relevant EU funding for semi / PV group members

August 31, 2010 2:36 pm | by I-Micronews | News | Comments

The European Commission NMP work programme 2011 has a budget of EUR 300 million (up from 98 million in 2010) in addition to EUR 130 million for PPPs (Public Private Partnerships).

pSivida drug target gets FDA priority review

August 31, 2010 2:36 pm | by Mass High Tech: The Journal of New England Technology | News | Comments

The U.S. Food and Drug Administration has granted priority review status for the New Drug Application of Iluvien, the lead product of Watertown-based biotechnology company pSivida Corp. and intended to treat diabetic macular edema.

Reportlinker Adds Urological Disorders Therapeutics to 2016 - Increasing Awareness and Aging Population will Drive the Benign Prostatic Hyperplasia and Urinary Incontinence Ma...

August 31, 2010 2:35 pm | by Bio-Medicine.Org | News | Comments

NEW YORK, Aug. 31 /- Reportlinker.com announces that a new market research report is available in its catalogue: Urological Disorders Therapeutics to 2016 - Increasing Awareness and Aging Population will Drive the Benign Prostatic Hyperplasia and Urinary Incontinence Markets...

TOPICS:

Reportlinker Adds All Change in the Coronary Stent Market

August 31, 2010 2:35 pm | by Bio-Medicine.Org | News | Comments

NEW YORK, Aug. 31 /- Reportlinker.com announces that a new market research report is available in its catalogue: All Change in the Coronary Stent Market http://www.reportlinker.com/p0203108/All-Change-in-the-Coronary-Stent-Market.html Use this report to… Review the prospects for key...

TOPICS:

Reportlinker Adds The Global Orthobiologics Market - Players, products and technologies driving change 2008

August 31, 2010 2:35 pm | by Bio-Medicine.Org | News | Comments

NEW YORK, Aug. 31 /- Reportlinker.com announces that a new market research report is available in its catalogue: The Global Orthobiologics Market - Players, products and technologies driving change 2008...

TOPICS:

Preventive cancer surgeries save women's lives

August 31, 2010 2:34 pm | by EurekAlert | News | Comments

(Northwestern University) A new study underscores the importance for women with a family history of breast or ovarian cancer to get genetic testing for the BRCA1 and BRCA2 genes that make them more likely to develop lethal breast or ovarian cancer, says a Northwestern Medicine oncologist....

TOPICS:

Increasing Selenium Intake May Decrease Bladder Cancer Risk

August 31, 2010 2:33 pm | by AACR | News | Comments

According to results of a study published in the September issue of Cancer Epidemiology, Biomarkers & Prevention, a journal of the American Association for Cancer Research, selenium intake is associated with decreased risk of bladder cancer.

TOPICS:

Pages

X
You may login with either your assigned username or your e-mail address.
The password field is case sensitive.
Loading